Role of Pharmaceutical Companies in Commodity Security By Md. - PowerPoint PPT Presentation

Role of Pharmaceutical Companies in Commodity Security By Md. Rafiqul Islam Marketing Manager Dhaka, Bangladesh

Basic Needs • Food • Clothes • Accommodation • Medicine • Education

Accommodation, clothes and education can however be compromised with as far as the quality is concerned but quality of food and medicine can not be compromised.

Quality requirement of food is similar to medicines as it ensures health quality maintenance.

What is RHCS RHCS is defined as ensuring a secure supply and choice of quality contraceptives and other reproductive health commodities to meet every person's needs at the right time and in the right place.

Highlights on some vital data of Bangladesh

Bangladesh Demographic Profile Population 127 m Population 127 m Population Density (Per Sq. Km) 867presons Population Density (Per Sq. Km) 867presons Population growth per annum 1.5% Population growth per annum 1.5% Urban population 21% Urban population 21% Per Capita Income < $ 400 Per Capita Income < $ 400 Literacy (5 + yearss) 56% Literacy (5 + yearss) 56% Source: According to GOB Data Sheet-1999

Vital Statistics of Health & Family Planing Sector Population per doctor 4581 Population per doctor 4581 Per capita government expenditure on health Per capita government expenditure on health $ 4.00 $ 4.00 and family planning and family planning 61 yr. Life expectancy at birth 61 yr. Life expectancy at birth Fertility Rate(per 1000 live births) 3.3 Fertility Rate(per 1000 live births) 3.3 19.9 Crude birth rate(per 1000 live births) 19.9 Crude birth rate(per 1000 live births) Crude death rate(per 1000 live births) 4.8 Crude death rate(per 1000 live births) 4.8 57 Infant mortality (both sexes) per 1000 live births 57 Infant mortality (both sexes) per 1000 live births Maternal Mortality Rate (per 1000 live births) 3 Maternal Mortality Rate (per 1000 live births) 3 31.80 31.80 No. of Women in Reproductive age group (15-49 years) No. of Women in Reproductive age group (15-49 years) million million Source: Bangladesh Data Sheet 1999.

Prevalence of Morbidity among Population of all ages from the selected Diseases per 1000 population during mid April 1997 to mid July 1997

Most common Diseases Both Sex Male Female 105.25 107.13 103.26 Total Fever/FUO 18.48 18.23 18.76 Common cold/ARI 16.15 17.13 15.10 Influenza 15.80 16.35 15.21 Dyspepsia/Gastritis/Peptic ulcer 10.81 10.51 11.12 Diarrhoea 9.12 9.56 8.66 Dysentery 5.99 5.97 6.01 Acute cough/Bronchitis 5.01 5.90 4.06 Malaria 4.57 4.88 4.24 Asthma 3.80 4.57 2.97 3.72 3.28 4.20 High blood pressure Malnutrition/Anaemia 3.32 2.42 4.24 Gout 2.90 2.73 3.08 2.23 1.88 2.61 Waist pain Typhoid 1.93 2.08 1.77 Scabies 1.42 1.64 1.20 Source: Statistical pocketbook of Bangladesh 1999

Reproductive morbidity (15-49)* Female Total 1.56 Normal delivery 0.11 Pregnancy with acute problems 0.11 Abortion 0.14 Delivery with problems 0.07 Bleeding after delivery 0.11 Bleeding at delivery 0.04 Suteka 0.40 Malnutrition/Anaemia 0.58 Source: Statistical pocketbook of Bangladesh 1999

Immunizable Diseases Both Male Female Sex Total 2.76 276 275 Measles 1.65 1.77 1.52 Poliomyelitis 0.11 0.07 0.14 Tetanus 0.14 0.10 0.18 Whooping cough 0.47 0.48 0.47 Tuberculosis 0.39 0.34 0.43 Diphtheria - - - Other disease 30.97 29.84 30.60 * Includes females aged<15 and 50+, FUO = Fever of unknown origin, ARI = Acute respiratory infection. Source: Statistical pocketbook of Bangladesh 1999

Total market size of Pharmaceutical Products in Bangladesh in 2000 above 18,633 millions (million) Alimentary t.& Metabolism 5,338 Blood+b.forming organs 269 Cardiovascular system 832 Dermatologicals 605 G.u. System & sex hormones 405 Systemic hormones 231 Systemic anti-infectives 5,855 Hospital solutions 459 Antineoplast+immunomodul 18.00 Musculo-skeletal system 1025 Central nervous system 1391 Parasitology 539 Respiratory system 1296 Sensory organs 322 Diagnostic agents 0.5 Various 47 Total 18,633 Source - IMS Report

Achievements of the family planning program in Bangladesh 7.0 60.0 6.0 50.0 5.0 40.0 4.0 Percantage 30.0 3.0 20.0 2.0 10.0 1.0 TFR CPR 0.0 0.0 75 84 87 90 93 96 99 Calendar year Source - Bangladesh Demographic & Health Survey 1999-2000

Knowledge and use of family planning methods Percentage of ever-married and currently married women who know a family planning method, who have ever used a method, and who are currently using a method, by specific method, Bangladesh 1990-2000 Percent who know Percent who ever Percent currently a family planning used a family using a family method planning method planning method Contraceptive method EMW CMW EMW CMW CMW Any method 99.9 99.9 74.6 77.8 53.8 Any modern method 99.9 99.9 67.9 71.2 43.4 99.7 99.8 55.4 58.2 23.0 Pill 89.0 89.6 6.9 7.2 1.2 IUD 97.8 98.1 20.1 21.3 7.2 Injectables Implant/Norplant 55.5 56.3 0.6 0.7 0.5 Condom 89.0 89.8 18.6 19.7 4.3 Female sterilization 97.4 97.5 6.6 6.7 6.7 Male Sterilization 76.6 77.0 0.6 0.6 0.5 Any traditional method 78.3 79.3 28.7 29.8 10.3 Periodic abstinence 66.1 66.9 18.9 19.5 5.4 Withdrawal 55.7 56.8 14.0 14.7 4.0 Lactational amenorrhea method ( LAM) 16.0 16.2 0.7 0.7 0.0 Other methods 7.6 7.8 2.4 2.5 0.9 Number of women 10,544 9,720 10,544 9,720 9,720 EMW = ever-married women CMW = Currently married women Source: Bangladesh Demographic and Health Survey 1999-2000

3 Year Rolling Service Delivery Quantity for Cost (Taka in Type of Contraceptive Unit GOB,NGO and SMC Thousand Condom Piece 625,000,000 1,031,250 Low dose Oral Pill Cycle 145,000,000 1,172,083 Box 178,000 1,223,750 Combined DDS Kits MPA-injectable Contraceptive dose 31,000,000 1,364,000 Implantable Contraceptive Set 253,000 305,745 (Norplant) and tracer with Cannulae MR kit Kit 37,000 71,225 Gt dose Oral Pill cycle 614,625 6,161 Copper T 200B (UD) Set 425,000 9,350 Total Taka in Thousand ≈ 5,183 million 5,183 million in 3 years 1700 million in 1year ≈ $ 31 million

Scope of Pharmaceutical Industries to Produce RHC in Bangladesh 1. Strength ☺ Population : 129 millions ☺ Government procurement system ☺ Cheap labor and distribution ☺ Latex production ☺ All Companies follow WHO recommended CGMP & some of them are ISO standard.

Scope of Pharmaceutical Industries to Produce RHC in Bangladesh 2. Limitation ☺ Developed Countries Protectionism ☺ Trips Agreement ☺ Tariff and non-tariff barriers

Scope of Pharmaceutical Industries to Produce RHC in Bangladesh 3. Opportunity ☺ No Pharmaceutical Company is producing RHC except one ☺ No competition at all. ☺ Awareness: Knowledge of at least one family planning method is universal among Bangladesh women

Scope of Pharmaceutical Industries to Produce RHC in Bangladesh 4. Threat ☺ WTO & Trips Agreement ☺ Donor Agencies withdrawal

Recommendation Technology sharing and Technology Transfer ☺ Joint Venture Production Plant ☺ Limited International Bidding System within ☺ partner countries Partner should have reserved fund for Social ☺ Awareness through Seminar, mass media & advertisement about Family Planning & RHC.

Recommendation Government & Other agencies should give ☺ support to RHC producing industries Tariff and non-tariff barriers should be ☺ minimize as much as possible. Sharing of market segmentation studies ☺ by different pharma In Each partner countries, a special team ☺ should be formed comprising of overnment; private entrepreneur, and Partner secretariat

Recommendation This team will promote (by means of cafeteria ☺ approach) on issues of RHCs to private entrepreneur thereby encouraging the private entrepreneur to manufacture RHC. They will also act as a coordinator between government and private entrepreneur to do what ever is necessary to meet the procedural barriers.

Source: Taken Form: Harvard Business Review Magazine